LONG BEACH, Calif. — Big Data may provide some answers to the many questions surrounding advanced catheter-based pulmonary embolism (PE) therapies, a buzzing field that otherwise has little evidence from real-world practice due in part to the lack of a national registry.
In an exploratory analysis of de-identified electronic health records (EHRs), investigators found 435,296 patients with a PE diagnosis from January 2018 through May 2023, of whom 0.48% were logged as having received advanced therapy with either the mechanical thrombectomy FlowTriever or EKOS ultrasound-guided catheter-directed thrombolysis system.
Interrogating disparities of care, researchers found Black people (0.37% vs 0.50% for non-Blacks, P
>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : MedPageToday – https://www.medpagetoday.com/meetingcoverage/scai/109966
